Table 2 Baseline characteristics of the study population
Characteristic | Study cohort (N = 130) |
|---|---|
Age (years), median [IQR] | 62.5 [58–69] |
ASA score, median [IQR] | 2 [1–2] |
IIEF-5 score, median [IQR] | 6 [5–7] |
Time between ED and PP implant (months), median [IQR] | 38 [24–72] |
Primary cause of ED, n (%) | |
Diabetes | 35 (26.9) |
Radical prostatectomy | 59 (45.4) |
Priapism/penile trauma | 6 (4.6) |
Spinal cord injury | 2 (1.5) |
Peyronie’s disease | 8 (6.2) |
Iatrogenic | 4 (3.1) |
Others | 16 (12.3) |
Previous ED treatment, n (%) | |
PDE5-I | 69 (53.1) |
Intracavernous injection | 122 (93.8) |
Penile prothesis | 5 (3.8) |
Vacuum | 9 (6.9) |
PP type, n (%) | |
AMS 700 | 76 (58.5) |
Coloplast Titan | 54 (41.5) |
Surgical approach, n (%) | |
Peno-scrotal | 96 (73.8) |
Infra-pubic | 34 (26.2) |
Follow-up (years), median [IQR] | 6.3 ± [4–9.4] |